DERIVATIVES OF THE POTENT ANGIOTENSIN CONVERTING ENZYME INHIBITOR 5(S)-BENZAMIDO-4-OXO-6-PHENYLHEXANOYL-L-PROLINE: EFFECT OF CHANGES AT POSTIONS 2 AND 5 OF THE HEXANOIC ACID PORTION